DAPK1 and cancer: DAPK family members were postulated to act as tumor suppressors, as a decreased expression was found in several cancer entities (including bladder, breast, renal cell carcinoma, lymphoma, prostate, and brain tumors) due to epigenetic silencing through promoter methylation and also to loss of heterozygosity [53].